Suppr超能文献

机器人辅助与传统腹腔镜根治性子宫切除术治疗宫颈癌 IB1 期的比较。

Robot-assisted versus conventional laparoscopic radical hysterectomy in cervical cancer stage IB1.

机构信息

Department of Obstetrics and Gynecology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Department of Obstetrics and Gynecology, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

出版信息

Int J Med Sci. 2023 Jan 22;20(3):287-291. doi: 10.7150/ijms.79830. eCollection 2023.

Abstract

The aim of this study was to compare survival outcomes of robot-assisted laparoscopic radical hysterectomy (RRH) and conventional laparoscopic radical hysterectomy (LRH) in cervical cancer stage IB1. This is a retrospective study of patients with cervical cancer stage IB1 who surgically treated by either RRH or LRH. Oncologic outcomes of the patients were compared according to surgical approach. In total, 66 and 29 patients were assigned to LRH and RRH groups. All patients had stage IB1 disease (FIGO 2018). Intermediate risk factors (tumor size, LVSI, and deep stromal invasion), proportion of patients receiving adjuvant therapy (30.3% vs. 13.8%, p = 0.09), and median follow-up time (LRH, 61 months; RRH, 50 months; p=0.085) did not differ significantly between the two groups. The recurrence rate was higher in the LRH group; however, there was no significant difference between the two groups (p=0.250). DFS (55.4 vs 48.2 months, p = 0.250), and OS (61.2 vs 50.0 months, p = 0.287) were similar between the LRH and RRH groups. In patients with a tumor size < 2 cm, the recurrence rate was lower in RRH group; however, there was no significant difference. Further large-scale RCTs and clinical studies are required to provide relevant data.

摘要

本研究旨在比较宫颈癌 IB1 期患者行机器人辅助腹腔镜根治性子宫切除术(RRH)与传统腹腔镜根治性子宫切除术(LRH)的生存结局。这是一项回顾性研究,纳入了接受 RRH 或 LRH 治疗的宫颈癌 IB1 期患者。根据手术方式比较患者的肿瘤学结局。共有 66 例和 29 例患者分别被分配至 LRH 和 RRH 组。所有患者均为 IB1 期疾病(FIGO 2018)。两组患者的中危因素(肿瘤大小、脉管间隙浸润、深层间质浸润)、接受辅助治疗的患者比例(30.3% vs. 13.8%,p = 0.09)和中位随访时间(LRH:61 个月;RRH:50 个月;p=0.085)无显著差异。LRH 组的复发率较高,但两组间无显著差异(p=0.250)。LRH 组和 RRH 组的无病生存率(DFS)(55.4 个月比 48.2 个月,p = 0.250)和总生存率(OS)(61.2 个月比 50.0 个月,p = 0.287)相似。肿瘤大小<2cm 的患者中,RRH 组的复发率较低,但无显著差异。需要进一步开展大规模 RCT 和临床研究以提供相关数据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c62f/9969504/ae1aeab9cbaa/ijmsv20p0287g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验